Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Carcinoma (CRC) Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00419159
What this trial is testing

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Who this might be right for
Colorectal Cancer
Novartis Pharmaceuticals 199
Not applicableUnknownNCT04131803
What this trial is testing

Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 140
Early research (Phase 1)Study completedNCT03087591
What this trial is testing

APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more
Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Testing effectiveness (Phase 2)Study completedNCT00290615
What this trial is testing

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Herbert Hurwitz 30
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT03695835
What this trial is testing

A Data Collection Study for Patients With Adenocarcinoma Treated With the MyVaccx Immunotherapy Regimen.

Who this might be right for
Adenocarcinoma
Gary Onik MD 27
Post-approval studies (Phase 4)Ended earlyNCT00327093
What this trial is testing

Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Hospices Civils de Lyon 31
Testing effectiveness (Phase 2)Ended earlyNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 14
Not applicableStudy completedNCT01904955
What this trial is testing

Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort

Who this might be right for
Colorectal Cancer
Centre Hospitalier Universitaire Dijon 598
Testing effectiveness (Phase 2)Looking for participantsNCT05310643
What this trial is testing

Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 30
Early research (Phase 1)Study completedNCT00343408
What this trial is testing

AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerLung Cancer
NCIC Clinical Trials Group 31
Not applicableStudy completedNCT06593678
What this trial is testing

Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection

Who this might be right for
Colorectal CancerTelerehabilitationPhysical Therapy
Instituto de Investigación Sanitaria Aragón 80
Not applicableStudy completedNCT04482608
What this trial is testing

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival

Who this might be right for
Colorectal Cancer MetastaticMismatch Repair DeficiencyMicrosatellite Instability High
Sun Yat-sen University 671
Early research (Phase 1)Ended earlyNCT06336148
What this trial is testing

A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT05193292
What this trial is testing

Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsIntestinal Neoplasms
Fudan University 77
Testing effectiveness (Phase 2)UnknownNCT03126071
What this trial is testing

Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital 100
Testing effectiveness (Phase 2)UnknownNCT05684211
What this trial is testing

Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Celfuture Biotech Co., Ltd. 84
Not applicableStudy completedNCT01344304
What this trial is testing

Study of Aprepitant / Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in Colorectal Cancer Patients - SENRI Trial

Who this might be right for
Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group 413
Testing effectiveness (Phase 2)Study completedNCT00048126
What this trial is testing

Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 57
Next Page